Carlyle Group (CG)
(Delayed Data from NSDQ)
$46.33 USD
+1.59 (3.55%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $46.35 +0.02 (0.04%) 5:04 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CG 46.33 +1.59(3.55%)
Will CG be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CG
Why Carlyle Group (CG) is a Top Dividend Stock for Your Portfolio
Discover (DFS) Q2 Earnings Beat on High Interest Income
CG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?
Carlyle Group (CG) Eyes Buyout of Baxter's Kidney Care Unit
Company News for July 8, 2024
Other News for CG
Carlyle Credit Income Fund Schedules Third Quarter 2024 Financial Results and Investor Conference Call
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
Carlyle lines up $3B credit facility for Baxter unit, Bloomberg reports
Artisan Mid Cap Value Fund Q2 2024 Commentary
Moderna appoints David Rubenstein to board of directors